{"id":2877,"date":"2026-06-01T12:00:00","date_gmt":"2026-06-01T15:00:00","guid":{"rendered":"https:\/\/bye.nexsa.cl\/isp-abre-consulta-publica-sobre-nuevo-instructivo-de-control-de-serie-de-productos-farmaceuticos-biologicos\/"},"modified":"2026-10-06T22:17:22","modified_gmt":"2026-10-07T01:17:22","slug":"isp-abre-consulta-publica-sobre-nuevo-instructivo-de-control-de-serie-de-productos-farmaceuticos-biologicos","status":"publish","type":"post","link":"https:\/\/www.bye.cl\/en\/isp-abre-consulta-publica-sobre-nuevo-instructivo-de-control-de-serie-de-productos-farmaceuticos-biologicos\/","title":{"rendered":"Barros &amp; Err\u00e1zuriz advised JX Advanced Metals Corporation"},"content":{"rendered":"<p>El Instituto de Salud P\u00fablica de Chile (ISP) ha sometido a consulta p\u00fablica el proyecto de Resoluci\u00f3n Exenta N\u00b0 129 (Resoluci\u00f3n N\u00b0 129), de fecha 14 de mayo de 2026, que aprueba un nuevo \u201cInstructivo para el usuario sobre el control de serie de productos biol\u00f3gicos y liberaci\u00f3n de lotes de productos farmac\u00e9uticos de uso humano y sus tr\u00e1mites asociados\u201d. La consulta estar\u00e1 disponible entre el 25 de mayo y el 25 de junio de 2026.<\/p>\n<p>Nuestro equipo de Derecho P\u00fablico realiz\u00f3 un escrito sobre el tema.<\/p>\n<p><a href=\"https:\/\/statics.teams.cdn.office.net\/evergreen-assets\/safelinks\/2\/atp-safelinks.html\">Rev\u00edsalo Aqu\u00ed.&nbsp;<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>El Instituto de Salud P\u00fablica de Chile (ISP) ha sometido a consulta p\u00fablica el proyecto de Resoluci\u00f3n Exenta N\u00b0 129 (Resoluci\u00f3n N\u00b0 129), de fecha 14 de mayo de 2026, que aprueba un nuevo \u201cInstructivo<\/p>","protected":false},"author":1,"featured_media":2839,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_bye_card_image":2837,"_bye_lawyers":[],"_bye_areas":[37],"_bye_document":0,"_bye_document_url":"","_bye_document_label":"","_bye_old_id":29112,"_bye_old_path":"\/isp-abre-consulta-publica-sobre-nuevo-instructivo-de-control-de-serie-de-productos-farmaceuticos-biologicos\/","_bye_translation":"","footnotes":""},"categories":[1],"tags":[],"tipo_publicacion":[7],"industria":[],"class_list":["post-2877","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-sin-categoria"],"_links":{"self":[{"href":"https:\/\/www.bye.cl\/en\/wp-json\/wp\/v2\/posts\/2877","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.bye.cl\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.bye.cl\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.bye.cl\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.bye.cl\/en\/wp-json\/wp\/v2\/comments?post=2877"}],"version-history":[{"count":0,"href":"https:\/\/www.bye.cl\/en\/wp-json\/wp\/v2\/posts\/2877\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.bye.cl\/en\/wp-json\/wp\/v2\/media\/2839"}],"wp:attachment":[{"href":"https:\/\/www.bye.cl\/en\/wp-json\/wp\/v2\/media?parent=2877"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.bye.cl\/en\/wp-json\/wp\/v2\/categories?post=2877"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.bye.cl\/en\/wp-json\/wp\/v2\/tags?post=2877"},{"taxonomy":"tipo_publicacion","embeddable":true,"href":"https:\/\/www.bye.cl\/en\/wp-json\/wp\/v2\/tipo_publicacion?post=2877"},{"taxonomy":"industria","embeddable":true,"href":"https:\/\/www.bye.cl\/en\/wp-json\/wp\/v2\/industria?post=2877"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}